Found 8 matching trials
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1,Chemotherapy and Target Therapy for Metastatic Colorectal Cancer PHASE2 To improve the survival in patients with microsatellite stable metastatic c...
Show More Learn More & Join Trial
HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer NA Biliary tract cancer (BTC), including cholangiocarcinoma and gallbladder ca...
Show More Location
Peking University Cancer Hospital
Learn More & Join Trial
Localized Treatment Versus Palliative Chemotherapy in CRC Patients With 10 or More CRLM PHASE3 The goal of this clinical trial is to investigate the effectiveness of loca...
Show More Location
Sun Yat-sen Cancer Center
Learn More & Join Trial
Combination of High and Low-Dose Radiotherapy With Immune Therapy and TKI in Advanced Colorectal Cancer: A Phase II Study PHASE2 The goal of this clinical trial is to learn whether a high- and low-dose ra...
Show More Location
Multiple Locations
Learn More & Join Trial
Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment PHASE2 Approximately 70% of hepatocellular carcinoma (HCC) patients are diagnosed ...
Show More Location
Multiple Locations
Learn More & Join Trial
Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer PHASE3 The goal of this clinical trial is to learn if Stereotactic Body Radiothera...
Show More Location
Second Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
Local Consolidative Radiotherapy for Oligoprogressive in Non-small Cell Lung Carcinoma PHASE2 This is a randomized phase II study designed to evaluate the effect of loca...
Show More Location
Multiple Locations
Learn More & Join Trial
Iadademstat + SBRT With Atezo in ES-SCLC PHASE1 This is a phase 1b dose escalation, open-label, non-randomized study of par...
Show More Learn More & Join Trial